FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: CPRX

Sort
E.g., 2013-05-23
E.g., 2013-05-23
Enter a comma separated list of user names.

Catalyst Pharmaceutical Partners Inc. (Nasdaq:CPRX) announced that its investigational drug, CPP-115, a novel GABA aminotransferase inhibitor, has been designated as a Fast Track development program by the FDA for the treatment of cocaine dependency.

Tags:

Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) witnessed volume of 981,486.00 shares during last trade however it holds an average trading capacity of 67,958.00 shares. CPRX last trade opened at $1.25 reached intraday low of $1.02 and went -19.23% down to close at $1.05.

Stock-PR Reporting

FREE Daily Stock Alerts From Stock-PR.com

Tags:

Saba Announces First Quarter Fiscal Year 2012 Results

Total quarterly billings up 18% with cloud billings growing 81% year-over-year

Cloud revenue grew 59% year-over-year

Subscription revenue up 26% year-over-year; representing 61% of total revenues

Subscription revenue gross margin expanded to 77%

Tags:

Pages

ADVERTISE WITH US